Development and Validation of a HAUS-Related Prognostic Signature in Liver Hepatocellular Carcinoma: A Multi-Omics Integration from Pan-Cancer Analysis to Single-Cell Resolution
Yanli Liu, Kang Liu, Yang Ding, Xiaodong Li, Xuanxuan Shi, Junrui Zhang, Xiangyue Zhang, Weiyao Peng, Jingyi Deng, Jingqi Chen · 2026
Read Development and Validation of a HAUS-Related Prognostic Signature in Liver Hepatocellular Carcinoma: A Multi-Omics Integration from Pan-Cancer Analysis to Single-Cell Resolution by Yanli Liu, Kang Liu, Yang Ding, Xiaodong Li, Xuanxuan Shi, Junrui Zhang, Xiangyue Zhang, Weiyao Peng, Jingyi Deng, Jingqi Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13206321.txt.
Description
Yanli Liu and co-authors build a risk signature for liver cancer in a 2026 study. The signature rests on the HAUS gene family, which helps build the spindle that splits cells. Whether these genes drive cancer broadly or only in spots was unclear.
Across thirty-three cancer types in a large atlas, most HAUS genes ran high and tracked poor outcomes. In liver cancer, two gene-based subtypes split sharply on survival and immune traits. A score built from the family was checked in a second cohort and in lab tissue tests. The work gives a candidate tool for sorting liver patients by risk.
Catalog record
| CREATOR | Yanli Liu, Kang Liu, Yang Ding, Xiaodong Li, Xuanxuan Shi, Junrui Zhang, Xiangyue Zhang, Weiyao Peng, Jingyi Deng, Jingqi Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |